Helios Capital Management’s Boston Scientific BSX Stock Holding History

Helios Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$1.43M	–	24
2025 Q4	$1.43M	Hold	15,000	–	–	0.98%	22
2025 Q3	$1.46M	Hold	15,000	–	–	0.99%	24
2025 Q2	$1.61M	Hold	15,000	–	–	1.24%	21
2025 Q1	$1.51M	Hold	15,000	–	–	2.65%	8
2024 Q4	$1.34M	Hold	15,000	–	–	0.78%	24
2024 Q3	$1.26M	Hold	15,000	–	–	0.77%	25
2024 Q2	$1.16M	Hold	15,000	–	–	0.75%	28
2024 Q1	$1.03M	Hold	15,000	–	–	0.72%	32
2023 Q4	$867K	Buy	+15,000	New	+$801K	0.69%	33
2022 Q3	$581K	Hold	15,000	–	–	1.11%	31
2022 Q2	$559K	Hold	15,000	–	–	1.05%	29
2022 Q1	$664K	Hold	15,000	–	–	1.4%	24
2021 Q4	$637K	Buy	+15,000	New	+$630K	0.58%	51

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Helios Capital Management's BSX Position: Q1 2026 in Review

Helios Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 15,000 shares — an estimated $1.43M sold.

Helios Capital Management first reported a position in BSX in Q4 2021 and held it in 13 quarters. The position peaked at $1.61M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Helios Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Helios Capital Management sold 15,000 Boston Scientific shares in Q1 2026, an estimated $1.43M.
Helios Capital Management first reported a position in Boston Scientific in Q4 2021 and held it in 13 quarters.
Helios Capital Management's Boston Scientific position peaked at $1.61M in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Helios Capital Management's 13F filing for Q1 2026, filed 5 May 2026.